Ingevity (NYSE:NGVT) Updates FY 2026 Earnings Guidance

Ingevity (NYSE:NGVTGet Free Report) issued an update on its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 5.000-5.450 for the period, compared to the consensus EPS estimate of 4.950. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.1 billion.

Ingevity Price Performance

NGVT traded down $0.60 during midday trading on Thursday, hitting $70.02. The stock had a trading volume of 329,715 shares, compared to its average volume of 294,575. Ingevity has a 1 year low of $39.74 and a 1 year high of $79.29. The company has a debt-to-equity ratio of 27.83, a quick ratio of 0.92 and a current ratio of 1.42. The business has a fifty day moving average of $71.53 and a 200 day moving average of $70.91. The company has a market cap of $2.43 billion, a P/E ratio of -19.72 and a beta of 1.16.

Ingevity (NYSE:NGVTGet Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, beating the consensus estimate of $1.33 by $0.41. The company had revenue of $314.10 million for the quarter, compared to analyst estimates of $312.20 million. Ingevity had a negative net margin of 10.55% and a positive return on equity of 207.82%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, equities analysts forecast that Ingevity will post 5.05 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on NGVT shares. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a report on Friday, July 17th. Wall Street Zen raised Ingevity from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, July 7th. Two analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Ingevity has an average rating of “Hold” and a consensus price target of $80.00.

Get Our Latest Research Report on Ingevity

Insiders Place Their Bets

In other news, SVP Terrance M. Dyer sold 496 shares of Ingevity stock in a transaction that occurred on Thursday, May 28th. The stock was sold at an average price of $68.49, for a total value of $33,971.04. Following the sale, the senior vice president directly owned 7,202 shares in the company, valued at approximately $493,264.98. This trade represents a 6.44% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.88% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. California State Teachers Retirement System boosted its stake in shares of Ingevity by 1.6% during the 2nd quarter. California State Teachers Retirement System now owns 33,605 shares of the company’s stock valued at $1,448,000 after purchasing an additional 539 shares in the last quarter. Susquehanna Portfolio Strategies LLC bought a new position in Ingevity in the fourth quarter worth about $1,112,000. AQR Capital Management LLC lifted its holdings in Ingevity by 10.9% in the first quarter. AQR Capital Management LLC now owns 13,410 shares of the company’s stock worth $518,000 after buying an additional 1,323 shares during the period. iSAM Funds UK Ltd bought a new stake in Ingevity during the 3rd quarter valued at approximately $415,000. Finally, Entropy Technologies LP bought a new position in shares of Ingevity in the 3rd quarter worth approximately $361,000. 91.59% of the stock is owned by hedge funds and other institutional investors.

Ingevity Company Profile

(Get Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Read More

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.